These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12637123)

  • 21. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector.
    Gross ML; Kay J; Turner AM; Jewsbury J; Cleal AL
    Headache; 1995; 35(10):601-6. PubMed ID: 8550361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types.
    Ashford E; Salonen R; Saiers J; Woessner M
    Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of nasal sumatriptan in 5- to 12-year-old children.
    Hershey AD; Powers SW; LeCates S; Bentti AL
    Headache; 2001; 41(7):693-7. PubMed ID: 11554957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to assess patient preference of migraine treatments.
    Dahlöf C
    Cephalalgia; 1999 Jul; 19 Suppl 24():2-5; discussion 5-6. PubMed ID: 10526675
    [No Abstract]   [Full Text] [Related]  

  • 25. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A within-patient comparison of subcutaneous and oral sumatriptan in the acute treatment of migraine in general practice.
    Gruffydd-Jones K; Hood CA; Price DB
    Cephalalgia; 1997 Feb; 17(1):31-6. PubMed ID: 9051333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan: pharmacological basis and clinical results.
    Dahlöf CG
    Curr Med Res Opin; 2001; 17 Suppl 1():s35-45. PubMed ID: 12463276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open label study of intranasal sumatriptan (Imigran) for footballer's headache.
    McCrory P; Heywood J; Ugoni A
    Br J Sports Med; 2005 Aug; 39(8):552-4. PubMed ID: 16046342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
    van Vliet JA; Bahra A; Martin V; Ramadan N; Aurora SK; Mathew NT; Ferrari MD; Goadsby PJ
    Neurology; 2003 Feb; 60(4):630-3. PubMed ID: 12601104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine.
    Munjal S; Brand-Schieber E; Allenby K; Spierings ELH; Cady RK; Rapoport AM
    J Headache Pain; 2017 Dec; 18(1):31. PubMed ID: 28251391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group.
    Göbel H; Winter P; Boswell D; Crisp A; Becker W; Hauge T; Mihout B; Niewold J; Tørring J
    Clin Ther; 2000 Aug; 22(8):981-9. PubMed ID: 10972634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practicability and acceptance of subcutaneous self-administration of the selective serotonin agonist sumatriptan.
    Göbel H; Baar H; Beiküfner HD; Böhme K; Beckmann-Reinhold A
    Headache; 1998 Apr; 38(4):267-9. PubMed ID: 9595865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.